Is there a link between oestrogen therapy and gallbladder disease?

Bibliography

• DIEHL AK: Epidemiology and natural history of gallstone disease. Gastroenterol. Clin. North. Am. (1991) 20:1-19.
   PubMed Web of Science ®Google Scholar
• SIMON JA, HUDES ES: Serum ascorbic acid and gallbladder disease prevalence among US adults, the Third National Health and Nutrition Examination Survey (NHANES III). Arch. Intern. Med. (2000) 160:961-966.
   PubMed Web of Science ®Google Scholar
• GRAVES EJ, KOZAK LJ: National Hospital Discharge Survey: Annual Summary, 1996. National Centre for Health Statistics. Vital Health Stat. (1998) 13:140.
   Google Scholar
• PETERS KD, KOCHANEK KD, MURPHEY SL: National Vital Statistics, Report 47(9). Hyattsville, Maryland: National Center for Health Statistics (1998).
   Google Scholar
• NATIONAL INSTITUTES OF HEALTH: Consensus Development Conference statement on gallstones and laparoscopic cholecystectomy. Am. J. Surg. (1993) 165:390-398.
   PubMed Web of Science ®Google Scholar
• ROBERTSON HE: The preponderance of gallstones in women: an aetiological study. Int. Abstr. Surg. (1945) 80:1-5.
   Google Scholar
• FRIEDMAN GD, KANNEL WB, DAWBER TR: The epidemiology of gallbladder disease: observations in Framingham Study. J. Chronic Dis. (1966) 19:273-292.
   PubMedGoogle Scholar
• NILSSON S: Gallbladder disease and sex hormones: a statistical study. Acta. Chir. Scand. (1966) 132:275-279.
   PubMedGoogle Scholar
• HORN G: Observations on the aetiology of cholelithiasis. Br. Med. J. (1956) 2:732-737.
   Google Scholar
• PETITTI DB, FRIEDMAN GD, KLATSKY AL: Association of history of gallbladder disease with reduced concentration of high density lipoprotein cholesterol. N. Engl. J. Med. (1981) 304:1396-1398.
   PubMed Web of Science ®Google Scholar
• BOSTON COLLABORATIVE DRUG SURVEILLANCE PROGRAM (BCDSP): Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal oestrogen therapy. N. Engl. J. Med. (1974) 290:15-19.
   PubMed Web of Science ®Google Scholar
• HONORE LH: Increased incidence of symptomatic cholesterol cholelithiasis in perimenopausal women receiving estrogen replacement therapy; a retrospective study. J. Reprod. Med. (1980) 25:187-190.
   PubMed Web of Science ®Google Scholar
• PETITTI DB, SIDNEY S, PERLMAN JA: Increased risk of cholecystectomy in users of supplemental estrogen. Gastroenterology (1988) 94:91-95.
   Google Scholar
• GRODSTEIN F, COLDITZ GA, STAMPFER MU: Postmenopausal hormone use and cholecystectomy in a large prospective study. Obstet. Gynecol. (1994) 83:5-11.
   PubMed Web of Science ®Google Scholar
• MAMDANI MM, TU K, VAN WALRAVEN C, AUSTIN PC, NAYLOR CD: Postmenopausal estrogen replaceament therapy and increased rates of cholecystomy and appendectomy. CMAJ (2000) 162:1421-1424
   PubMed Web of Science ®Google Scholar
• BOLAND LL, FOLSOM AR, ROSAMOUND WD: Hyperisulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease: a prospective study. Ann. Epidemiol. (2002) 12:131-140.
   PubMed Web of Science ®Google Scholar
• NACHTIGALL LE, NACHTIGALL RH, NACHTIGALL RD, BECKMAN EM: Estrogen replacement Therapy II: a prospective study in the relationship and cardiovascular and metabolic problems. Obstet. Gynecol. (1979) 54:74-79.
   PubMed Web of Science ®Google Scholar
• SIMON JA, HUNNINGHAKE DB, AGARWAL SK et al.: Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease: the Heart and Estrogen/Progestin Replacement Study. Ann. Intern. Med. (2001) 135:493-501.
   PubMed Web of Science ®Google Scholar
• HULLEY S, FURBERG C, BARRETT-CONNOR E et al.: Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 288:58-66.
   PubMed Web of Science ®Google Scholar
• CIRILLO DJ, WALLACE RB, RODABOUGH RJ et al.: Effect of estrogen therapy on gallbladder disease. JAMA (2005) 293:330-339.
   PubMed Web of Science ®Google Scholar
• SCRAGG RKR, MCMICHAEL AJ, SEAMARK RF: Oral contraceptives, pregnancy and endogenous oestrogen in gallstone disease. A case control study. Br. Med. J. (1984) 288:1795-1799.
   PubMed Web of Science ®Google Scholar
• BARBARA L, SAMA C, MORSELLI LABATE AM et al.: A population study on the prevalence of gallstones disease: the Sirmione study. Hepatology (1987) 7:913-917.
   PubMed Web of Science ®Google Scholar
• THIJS G, KNIPSCHILD P, LEFFERS P: Pregnancy and gallstone disease: an empiric demonstration of the importance of specification of risk periods. Am. J. Epidemiol. (1991) 134:186-195.
   PubMed Web of Science ®Google Scholar
• KO CW, BERESFORD SAA, SCHUTTLE SJ, MATSUMOTO AM, LEE SP: Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology (2005) 41:359-365.
   PubMed Web of Science ®Google Scholar
• MARGINHINI A, CIAMBRA M, BACCELLLIERE P et al.: Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history. Ann. Intern. Med. (1993) 119:116-120.
   PubMed Web of Science ®Google Scholar
• TSIMOYIANNIS EC, ANTONIOU NC, TSABOULAS C, PAPANIKOLAOU N: Cholelithiasis during pregnancy and lactation. Eur. J. Surg. (1994) 160:627-631.
   PubMedGoogle Scholar
• KERN F JR, EVERSON GT, DEMARK B et al.: Biliary lipids, bile acids, and gallbladder function in the human female: effects of pregnancy and the ovulatory cycle. J. Clin. Invest. (1981) 68:1229-1292.
   PubMed Web of Science ®Google Scholar
• LEISSNER KH, WEDEL H, SCHERSTEN T: Comparison between the use of contraceptives and the incidence of surgically confirmed gallstone disease. Scand. J. Gastroenterol. (1977) 12:893-896.
   PubMed Web of Science ®Google Scholar
• DIEHL AK, STERN MP, OSTROWER VS, FRIEDMAN PC: Prevalence of clinical gallbladder disease in Maxican–American, Anglo, and black women. South Med. J. (1980) 73:438-443.
   PubMed Web of Science ®Google Scholar
• EVRON S, FRANKEL M, DIAMANT Y: Biliary disease in young women and its association with pregnancy or oral contraceptives. Int. Surg. (1982) 67:448-450.
   PubMedGoogle Scholar
• JORGENSEN T: Gallstones in a Danish population: fertility period, pregnancies, and exogenous female sex hormones. Gut (1988) 29:433-439.
   PubMed Web of Science ®Google Scholar
• VAN BEEK EJ, FARMER KC, MILLAR DM, BRUMMELKAMP WH: Gallstone disease in women younger than 30 years. Neth. J. Surg. (1991) 43:60-62.
   PubMedGoogle Scholar
• LA VECCHIA C, NEGRI E, D’AVANZO B, PARAZZINI F, GENTILE A, FRANCESCHI S: Oral contraceptives and non-contraceptive oestrogens in the risk of gallstone disease requiring surgery. J. Epidemiol. Community Health (1992) 46:234-236.
   PubMed Web of Science ®Google Scholar
• THIJS C, LEFFERS P, KNIPSCHILD P: Oral contraceptive use and the occurrence of gallstone disease – a case-control study. Prev. Med. (1993) 22:122-131.
   PubMed Web of Science ®Google Scholar
• KAKAR F, WEISS NS, STRITE SA: Non-contraceptive estrogen use and the risk of gallstone disease in women. Am. J. Public Health (1988) 78:564-566.
   PubMed Web of Science ®Google Scholar
• VESSEY M, DOLL R, PETO R et al.: A long-term follow up study of women using different methods of contraception – an interim report. J. Biosol. Sci. (1976) 8:373-427.
   PubMedGoogle Scholar
• LAYDE PM, VESSEY MP, YEATES D: Risk factors of gallbladder disease: a cohort study of young women attending family planning clinics. J. Epidemiol. Community Health (1982) 36:274-278.
   PubMed Web of Science ®Google Scholar
• VESSEY M, PAINTER R: Oral contraceptive use and benign gallbladder disease; revisited. Contraception (1994) 50:167-173.
   PubMed Web of Science ®Google Scholar
• ROYAL COLLEGE OF GENERAL PRACTITIONERS: Oral Contraceptive and health. London: Pitman Medical (1974).
   Google Scholar
• BOSTON COLLABORATIVE DRUG SURVEILLANCE PROGRAM (BCDSP): Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumors. Lancet (1973) 1:1399-1404.
   PubMed Web of Science ®Google Scholar
• WINGRAVE ST, KAY CR: Oral contraceptives and gallbladder disease. Lancet (1982) 2:957-959.
   PubMed Web of Science ®Google Scholar
• EVERSON RB, BYAR DP, BISCHOFF AJ: Estrogen predisposes to cholecystectomy but not to stones. Gastroenterology (1982) 82:4-8.
   PubMed Web of Science ®Google Scholar
• ANSBACHER R: Oral estrogen replacement and abdominal pain: a report of two cases. J. Reprod. Med. (1984) 29:881-882.
   Google Scholar
• RIDKER PM, HENNEKENS CH, RIFAI N, BURING JE, MANSON JE: Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation (1999) 100:713-716.
   PubMed Web of Science ®Google Scholar
• CUSHMAN M, LEGAULT C, BARRETT-CONNOR E et al.: Effect of postmenopausal hormones on inflammation sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) study. Circulation (1999) 100:717-722.
   PubMed Web of Science ®Google Scholar
• NEGUS SS, MELLO NK: Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement. J. Pharmacol. Exp. Ther. (1999) 290:1132-1140.
   PubMed Web of Science ®Google Scholar
• WRITING GROUP FOR THE WOMEN’S HEALTH INITIATIVE RISKS AND BENEFITS OF OESTROGEN PLUS PROGESTIN IN HEALTHY POSTMENOPAUSAL WOMEN: principal results from the Women’s Health Initiative randomized controlled trial. JAMA (2002) 288:321-333.
   PubMed Web of Science ®Google Scholar
• THE CORONARY DRUG PROJECT RESEARCH GROUP: Gallbladder disease as a side effect of drugs influencing lipid metabolism. N. Engl. J. Med. (1977) 296:1185-1190.
   PubMed Web of Science ®Google Scholar
• HENRIKSSON P, EINARSSON K, ERIKSSON A, KELTER U, ANGELIN B: Estrogen-induced gallstone formation in males. J. Clin. Invest. (1989) 84:811-816.
   PubMed Web of Science ®Google Scholar
• GALLUS S, NEGRI E, CHATENOUD L et al.: Post-menopausal hormonal therapy and gallbladder cancer risk. Int. J. Cancer (2002) 99:762-3.
   PubMed Web of Science ®Google Scholar
• DONOVAN JM: Physical and metabolic factors in gallstone pathogenesis. Gastroenterol. Clin. North. Am. (1999) 28:75-97.
   PubMed Web of Science ®Google Scholar
• CABRAL DJ, SMALL DM: Physical chemistry of bile. In: Schultz SG, Forte JG, Rauner BB, Eds. Handbook of Physiology – The gastrointestinal system III. Section 6, Baltimore: Waverly Press (1989):621-662.
   Google Scholar
• NILSELL K, ANGELIN B, LILJEQVIST L, EINARSSON K: Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol. Gastroenterology (1985) 89:287-293.
   PubMed Web of Science ®Google Scholar
• CORRADINI SG, ELISEI W, GIOVANNELLI L et al.: Impaired human gallbladder lipid absorpotion in cholesterol gallstone disease and its effect on cholesterol solubility in bile. Gastroenterology (2000) 118:912-920.
   PubMed Web of Science ®Google Scholar
• CAREY MC: Critical tables for calculating the cholesterol saturation of native bile. J. Lipid. Res. (1978) 19:945-955.
   PubMed Web of Science ®Google Scholar
• HOLAN KR, HOLZBACH RT, HERMANN RE, COOPERMAN AM, CLAFFEY WJ: Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology (1979) 77:611-617.
   PubMed Web of Science ®Google Scholar
• SHARMA BC, AGARWAL DK, DHIMAN RK, BAIJAL SS, CHOUDHURI G, SARASWAT VA: Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy. Gastroenterology (1998) 115:124-128.
   PubMed Web of Science ®Google Scholar
• DHIMAN RK, PHANISH MK, CHAWLA YK, DILAWARI JB: Gallbladder motility and lithogenicity of bile in patients with choledocholithiasis after endoscopic sphincterotomy. J. Hepatol. (1997) 26:1300-1305.
   PubMed Web of Science ®Google Scholar
• XU QW, SHAFFER EA: The potential site of impaired gallbladder contractility in an animal model of cholesterol gallstone disease. Gastroenterology (1996) 110:251-257
   PubMed Web of Science ®Google Scholar
• YU PR, CHEN Q, BIANCANI P, BEHR J: Membrane cholesterol alters gallbladder muscle contractility in prairie dogs. Am. J. Physiol. (1996) 34:G56-G61.
   Google Scholar
• BEHAR J, RHIM BY, THOMPSON V, BIANCANI P: Inositol triphosphate restores impaired human gallbladder motility associated with cholesterol stones. Gastroenterology (1993) 104:563-568.
   PubMed Web of Science ®Google Scholar
• HEATON KW, EMMETT PM, SYMES CL, BRADDON FE: An explanation for gallstones in normal-weight women: slow intestinal transit. Lancet (1993) 341:8-10.
   PubMed Web of Science ®Google Scholar
• SHODA J, HE B, TANAKA N et al.: Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying and small intestinal transit. Hepatology (1995) 21:1291-1302.
   PubMed Web of Science ®Google Scholar
• AZZAROLI F, MAZZELLA G, MAZZEO P et al.: Sluggish small bowel motility is involved in determining increased biliary deoxycholatic acid in cholesterol gallstone patients. Am. J. Gastroenterol. (1999) 94:2453-2459.
   PubMed Web of Science ®Google Scholar
• HUSSAINI SH, PEREIRA SP, MURPHY GM et al.: Deoxycholic acid influences cholesterol stabilization and microcrystal nucleation time in gallbladder bile. Hepatology (1995) 22:1735-1744.
   PubMed Web of Science ®Google Scholar
• STOLK MF, VAN DE HEIJNING BJ, VAN ERPECUM KJ, VAN DEN BROEK AM, RENOOIJ W, VAN BERGE-HENEGOUWEN GP: The effect of bile salt hydrophobicity on nucleation of several types of cholesterol crystals from model bile vesicles. J. Hepatol. (1994) 20:802-810.
   PubMed Web of Science ®Google Scholar
• BENNION LJ, GINSBERG RL, GERNICK MB, BENNETT PH: Effects of oral contraceptives on the gallbladder bile of normal women. N. Engl. J. Med. (1976) 294:189-192.
   PubMed Web of Science ®Google Scholar
• LYNN J, WILLIAMS L, O’BRIEN J, WITTENBERG J, EGDAHL RH: Effects of estrogen upon bile: implications with respect to gallstone formation. Ann. Surg. (1973) 178:514-524.
   PubMed Web of Science ®Google Scholar
• PERTSEMLIDIS P, PANVELIWALLA P, AHRENS EH, Jr: Effects of clofibrate and an estrogen progestin combination on fasting biliary lipids and cholic acid kinetics in map. Gastroenterology (1974) 65:565-573.
   Google Scholar
• KERN F JR, EVERSON GT, DEMARCK B et al.: Biliary lipids, bile acids and gallbladder function in the human female: effects of contraceptive steroids. J. Lab. Clin. Med. (1982) 99:798-805.
   PubMedGoogle Scholar
• KERN F JR, EVERSON GT: Contraceptive steroids increase cholesterol in bile: mechanisms of action. J. Lipid. Res. (1987) 28:828-830.
   PubMed Web of Science ®Google Scholar
• BENNISON LJ, MOTT DM, HOWARD BV: Oral contraceptives raise the cholesterol saturation of bile by increasing biliary cholesterol secretion. Metab. Clin. Exp. (1980) 29:18-22.
   PubMed Web of Science ®Google Scholar
• VAN DER WERF SDJ, VAN BERGE-HENEGOUWEN GP, RUBEN AT, PLASMA DMH: Biliary lipids, bile acid metabolism, gallbladder motor function and small intestinal transit during ingestion of a sub-fifty oral contraceptive. J. Hepatol. (1987) 4:318-326.
   PubMed Web of Science ®Google Scholar
• HEUMAN R, LARSSON-COHN U, HAMMAR M, TISELIUS HG: Effects of postmenopausal ethinylestradiol treatment on gallbladder bile. Maturitas (1980) 2:69-72.
   PubMed Web of Science ®Google Scholar
• ANDERSON A, JAMES OF, MACDONALD HS, SNOWBALL S, TAYLOR W: The effect of ethynyl oestradiol on biliary lipid composition in young men. Eur. J. Clin. Invest. (1980) 10:77-80.
   PubMed Web of Science ®Google Scholar
• DOWN RHL, WHITING MJ, WATTS JM, JONES W: Effects of synthetic oestrogens and pogestagens in oral contraceptives on bile lipid composition. Gut (1983) 24:253-259.
   PubMed Web of Science ®Google Scholar
• D’AMATO G, CAVALLINI A, MESSA C, MANGINI V, MISCIAGNA G: Serum and bile lipid levels in postmenopausal women after percutanous and oral natural estrogens. Am. J. Obstet.Gynecol. (1989) 160:600-601.
   PubMed Web of Science ®Google Scholar
• EVERSON GT, MCKINLEY C, KERN F: Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J. Clin. Invest. (1991) 87:236-247.
   Google Scholar
• DHIMAN RK, SARKAR PK, SHARMA A et al.: Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy. Dig. Dis. Sci. (2004) 49:1335-1341.
   PubMed Web of Science ®Google Scholar
• TIERNEY S, QIAN Z, BURROW C, LIPSETT PA, PITT HA, LILLEMOE KD: Estrogen inhibits sphincter of Oddi motility. J. Surg. Res. (1994) 57:69-73.
   PubMed Web of Science ®Google Scholar
• SHAFFER EA, TAYLOR PJ, LOGAN K, GADOMSKI S, CORENBLUM B: The effect of progestin on gallbladder function in young women. Am. J. Obstet. Gynecol. (1984) 148:504-507.
   PubMed Web of Science ®Google Scholar
• HOULD FS, FRIED GM, FAZEKAS AG, TREMBLAY S, MERSEREAU WA: Progesterone receptors regulate gallbladder motility. J. Surg. Res. (1988) 45:505-512.
   PubMed Web of Science ®Google Scholar
• RYAN JP, PELLECCHIA D: Effect of progesterone treatment on guinea pig gallbladder motility in vitro. Gastroenterology (1982) 83:81-83.
   PubMed Web of Science ®Google Scholar
• LAUFER LR, DEFAZIO JL, LU JK et al.: Estrogen replacement therapy by transdermal estradiol administration. Am. J. Obstet. Gynecol. (1983) 146:533-540.
   PubMed Web of Science ®Google Scholar
• CHETKOWSKI RJ, MELDRUM DR, STEINGOLD KA et al.: Biologic effects of transdermal estradiol. N. Eng J. Med. (1986) 314:1615-1620.
   PubMed Web of Science ®Google Scholar
• VAN ERPECUM KJ, VAN BERGE-HENEGOUWEN GP, VERSCHOOR L, STOELWINDER B, WILLEKENS FLH: Different hepatobiliary effects of transdermal and oral estradiol in postmenopausal women. Gastroenterology (1991) 100:482-488.
   PubMed Web of Science ®Google Scholar
• UHLER ML, MARKS JW, VOIGT BJ, JUDD HL: Comparison of the impact of transdermal versus oral oestrogen on biliary markers of gallstone formation in postmenopausal women. J. Clin. Endocrinol. Metab. (1998) 83:410-414.
   PubMed Web of Science ®Google Scholar
• US PREVENTIVE SERVICES TASK FORCE: Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. Ann. Intern. Med. (2002) 137:834-839.
   PubMed Web of Science ®Google Scholar
• WATHEN CN, FEIG DS, FEIGHTNER JW, ABRAMSON BL, CHEUNG AM: Canadian Task Force on Preventive Health Care. Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ (2004) 170:1535-1537.
   PubMed Web of Science ®Google Scholar
• MANSON JE, MARTIN KA: Clinical practice. Postmenopausal hormone-replacement therapy. N. Engl. J. Med. (2001) 345:34-40.
   PubMed Web of Science ®Google Scholar
• ANDERSON GL, LIMACHER M, ASSAF AR et al.: Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA (2004) 291:1701-1712.
   PubMed Web of Science ®Google Scholar